New clinical trial for HER2 breast cancer
HER-2 is a subtype of breast cancer. It is characterised because the cancer cell expresses the HER-2 receptor – a protein, that promotes the growth of cancer cells. In about one of every five breast cancers, the cancer cells have extra copies of the gene that makes the HER-2 protein. A new clinical trial, called The Shamrock […]